{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:21:18Z","timestamp":1787757678246,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Context and Aim:<\/jats:title>\n                    <jats:p>Safety of drug usage during pregnancy is of utmost importance. Unrestricted usage of drugs may lead to undesirable and unpredictable pregnancy outcomes. This study was designed to detect drug-related adverse pregnancy outcomes, perform prescription audit and develop a pregnancy drug registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Materials:<\/jats:title>\n                    <jats:p>A prospective observational study was conducted at a tertiary care hospital in northern India. Pregnant females attending antenatal clinic, irrespective of their duration of pregnancy were included in the study over a period of 1 year. The participants were followed up monthly during their pregnancy till the pregnancy outcome. Adverse pregnancy outcomes were evaluated and causality assessment was done using the WHO-UMC scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis:<\/jats:title>\n                    <jats:p>Descriptive and inferential statistical tools were used for appropriate variables. Regression model was used to establish relationship between factors proposed to be responsible for adverse pregnancy outcomes. Presence of adverse pregnancy outcome was used as an independent variable. Microsoft Excel and Strata (version 12) were used for statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total 326 pregnant women were screened out of which 305 were included in the final analysis. Mean age of participants was 27.82 (\u00b14.51) years. Pre-existing comorbidities were present in 4.26% of participants. Average number of drugs per participant was 6.32 (\u00b11.94). Most drugs prescribed to participants were from FDA category B (49.23%) and category A (33.60%). Mean ADR reported per patient was 1.16 (\u00b11.18) with involvement of musculoskeletal (56.42%) and gastrointestinal (7.16%) being most frequent. Adverse pregnancy outcomes were reported in 25 participants among which IUGR (24%) followed by IUD (20%) and ectopic pregnancy (16%) were most frequently observed. Multivariate logistic regression showed number of comorbidities (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.037) and number of drugs consumed during pregnancy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02) to be statistically significantly associated with occurrence of adverse pregnancy outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Pregnancy registries have been instrumental in detection of signals for further research in drug-related adverse outcomes. Inappropriate usage of drugs has been shown to be associated with adverse pregnancy outcomes. Our study warrants need for further well-designed studies on adverse pregnancy outcomes in larger patient populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_211_21","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T06:06:24Z","timestamp":1638425184000},"page":"4176-4181","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Drug related adverse pregnancy outcomes at a tertiary care hospital from the foothills of Himalayas"],"prefix":"10.4103","volume":"10","author":[{"given":"Chahat","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkapal","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Bahadur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Handu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Dhamija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-37-20240828","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"Use of over-the-counter medications during pregnancy","volume":"193","author":"Werler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R3-37-20240828","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.berh.2019.03.007","article-title":"Management of pregnancy and lactation","volume":"32","author":"Sammaritano","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R4-37-20240828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2004.04.022","article-title":"Risk of drug-induced congenital defects","volume":"117","author":"De Santis","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R5-37-20240828","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/bmj.312.7038.1053","article-title":"Drugs and the fetus","volume":"312","author":"Vallance","year":"1996","journal-title":"BMJ (Clinical Research ed"},{"key":"R6-37-20240828","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12978-018-0631-3","article-title":"Prevalence of adverse birth outcome and associated factors among women who delivered in Hawassa town governmental health institutions, south Ethiopia, in 2017","volume":"15","author":"Tsegaye","year":"2018","journal-title":"Reprod Health"},{"key":"R7-37-20240828","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12884-019-2229-3","article-title":"Adverse pregnancy outcomes, \u2018stillbirths and early neonatal deaths\u2019 in Mutare district, Zimbabwe (2014): A descriptive study","volume":"19","author":"Chaibva","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"R8-37-20240828","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12978-020-0890-7","article-title":"Adverse pregnancy outcomes among women presenting at antenatal clinics in Ou\u00e9less\u00e9bougou, Mali","volume":"17","author":"Andemel","year":"2020","journal-title":"Reprod Health"},{"key":"R9-37-20240828","doi-asserted-by":"crossref","first-page":"75","DOI":"10.21106\/ijma.196","article-title":"Pregnancy outcomes in HIV-infected women: Experience from a tertiary care center in India","volume":"6","author":"Dadhwal","year":"2017","journal-title":"Int J MCH AIDS"},{"key":"R10-37-20240828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4172\/2167-0897.1000135","article-title":"Intrauterine growth retardation-A review article","volume":"3","author":"Murki","year":"2014","journal-title":"J Neonatal Biol"},{"key":"R11-37-20240828","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jgyn.2014.09.018","article-title":"Morts f\u0153tales in utero [In utero fetal death]","volume":"43","author":"Quibel","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris"},{"key":"R13-37-20240828","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/11591270-000000000-00000","article-title":"Drug exposure and pregnancy outcome in Mozambique","volume":"14","author":"Sevene","year":"2012","journal-title":"Paediatric Drugs"},{"key":"R14-37-20240828","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/1471-2393-14-322","article-title":"Medication exposure during regnancy: A pilot pharmacovigilance system using health and demographic surveillance platform","volume":"14","author":"Mosha","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"R15-37-20240828","first-page":"73","article-title":"Estimating the burden of \u2018weighing less\u2019 : A systematic review and meta-analysis of low birth-weight in India","volume":"29","author":"Bhilwar","year":"2016","journal-title":"Natl Med J India"},{"key":"R16-37-20240828","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/apt.15476","article-title":"Review article: Direct-acting antivirals for the treatment of HCV during pregnancy and lactation-implications for maternal dosing, foetal exposure, and safety for mother and child","volume":"50","author":"Freriksen","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-37-20240828","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/QAD.0b013e32834cdb71","article-title":"Safety of efavirenz in the first trimester of pregnancy: An updated systematic review and meta-analysis","volume":"25","author":"Ford","year":"2011","journal-title":"AIDS"},{"key":"R18-37-20240828","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2393-12-89","article-title":"Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings","volume":"12","author":"Mehta","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"key":"R19-37-20240828","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.322.7281.266","article-title":"Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: Population based observational study and case-control study","volume":"322","author":"Nielsen","year":"2001","journal-title":"BMJ"},{"key":"R20-37-20240828","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/bdra.20102","article-title":"Angiotensin II receptor antagonist treatment during pregnancy","volume":"73","author":"Alwan","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R21-37-20240828","first-page":"1987","article-title":"Acetaminophen use in pregnancy and neurodevelopment: Attention function and autism spectrum symptoms","volume":"45","author":"Avella-Garcia","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R22-37-20240828","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/1471-0528.12192","article-title":"Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: A prospective cohort study","volume":"120","author":"Nezvalov\u00e1-Henriksen","year":"2013","journal-title":"BJOG"},{"key":"R23-37-20240828","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.reprotox.2018.02.007","article-title":"Safety of diclofenac use during early pregnancy: A prospective observational cohort study","volume":"77","author":"Padberg","year":"2018","journal-title":"Reprod Toxicol"},{"key":"R24-37-20240828","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/oxfordjournals.aje.a010036","article-title":"Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes","volume":"150","author":"Ruig\u00f3mez","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R25-37-20240828","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00228-009-0713-9","article-title":"Montelukast use during pregnancy: A multicentre, prospective, comparative study of infant outcomes","volume":"65","author":"Sarkar","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"R26-37-20240828","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jogc.2017.10.024","article-title":"Ondansetron in pregnancy and the risk of congenital malformations: A systematic review","volume":"40","author":"Lavecchia","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"R27-37-20240828","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/AOG.0000000000001388","article-title":"Ondansetron use in pregnancy and birth defects: A systematic review","volume":"127","author":"Carstairs","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R28-37-20240828","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s13224-019-01301-8","article-title":"Maternal obesity and pregnancy outcome: In Perspective of New Asian Indian guidelines","volume":"70","author":"Kutchi","year":"2020","journal-title":"J Obstet Gynaecol India"},{"key":"R29-37-20240828","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.4103\/jfmpc.jfmpc_1230_20","article-title":"A prospective study to evaluate antimicrobial prescribing pattern among admitted patients in hilly Himalayan region of northern India","volume":"10","author":"Ravi","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"R30-37-20240828","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/picr.PICR_157_18","article-title":"A review of clinical studies involving pregnant women registered in the Clinical Trials Registry of India","volume":"11","author":"Karekar","year":"2020","journal-title":"Perspect Clin Res"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_211_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:47:20Z","timestamp":1787755640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_211_21"}},"subtitle":["A Prospective observational study"],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_211_21","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}